NovoStent addresses the physical limitations of current stent technology by integrating proprietary stent platforms with unique delivery technologies. NovoStent has created a new paradigm for stent therapy by linking a helical body to a radial anchor and by combining the most favorable attributes of the slotted tube and helical stents available today. The result is a self-expanding Nitinol platform which is first to offer variable scaffolding, enhanced and uniform drug delivery and superior flexibility without foreshortening. In addition, the customizable nature of the NovoStent platform allows us to provide physicians with unique design solutions in both the stent and low profile delivery systems.
